TetraScience, in partnership with NVIDIA’s BioNeMo Agent Toolkit, addresses a bottleneck in AI-driven drug discovery by transforming fragmented scientific data into machine-ready formats through its Scientific Data Foundry. The article demonstrates the approach with a Lead Clone Selection Assistant that compressed cell line development from 8 months to 2.5 months by integrating multiple data types and AI models.